Dapagliflozin(May include inactive ingredients varying by brand – check product label)
Treatment of type 2 diabetes mellitus (in adults) to improve glycemic control in combination with diet and exercise.
Reduction of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
Reduction of the risk of hospitalization for heart failure in adults with type 2 diabetes and chronic kidney disease.
Daplo 5 Tab (Dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works in the kidneys by blocking the reabsorption of glucose into the bloodstream, increasing its excretion in the urine. This leads to lower blood glucose levels and a reduction in cardiovascular risk factors.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Dosage varies depending on individual needs and other medications. Always follow your doctor's instructions.
Typically taken once daily, orally, with or without food.
Urinary tract infections (UTIs)
Genital yeast infections (candidiasis)
Dehydration
Increased urination
Ketoacidosis (rare but serious)
Hypotension (low blood pressure)
Hyperkalemia (high potassium levels)
Headache
Nausea
Constipation
Limit alcohol intake as it can increase dehydration risk.
May cause dizziness or lightheadedness; exercise caution.
Consult your doctor before use; not recommended during pregnancy or breastfeeding.
Not recommended for children.
Use with caution in patients with moderate to severe kidney disease. Dosage adjustment may be needed.
Dapagliflozin is primarily excreted by the kidneys, not extensively metabolized by the liver. However, liver function should be monitored in patients with hepatic impairment.
Your doctor and pharmacist
The official drug label for your specific dapagliflozin product
Reputable medical websites (e.g., FDA, Mayo Clinic, NHS)
